Pharmacological treatments anti-vascular endothelial growth factor(VEGF) could save the eyesight of exudative AMD patients, and gene therapies with Luxturn can delay the process of inherited retinal degeneration caused by mutations in the RPE65 gene. Here, VEGFA is linked to age-related macular degeneration.